Download complete cancer guide for prevention and
publication, Cesium therapy in cancer patients, Dr.
Sartori describes the 2 week treatment of 50 last
stage, metastasized, terminal cancer patients
(13 comatose), with Cesium salts. All were
expected to die within weeks, with the survival rate
being less than one in ten million. After 2
weeks, 13 died with autopsies showing no presence of
cancer. After 12 months, 12 more had died, but
25, an astounding 50% survived.
*Cesium has no natural radioactive form, and should
not be confused with Cesium 137 which is
Cancer cells are very weak, far weaker than healthy
cells. It is very easy to kill cancer cells if
you can create the right environment. The
following protocols are deadly to cancer cells, yet
harmless if not outright beneficial to healthy
The High pH Environment
Cancer cells live in an
acidic environment, but perish in an alkaline, high
pH, environment. Although many diets can help
you alkalinize your body, nothing works as fast as
Cesium Carbonate or Cesium Chloride.
Cesium for Cancer
Cesium *, a crystalline salt has been used
successfully for cancer for many years now.
Cesium Chloride and Cesium Carbonate work by raising
the cancer cell's Ph to a highly alkaline
state. Although many anti-cancer diets also
produce an alkaline state, they simply cannot do so
as quickly or as fully as Cesium can.
Cesium Therapy in Cancer patients
Certain foods contain biologically active compounds
and/or ingredients, i.e., vitamins, inorganic salts,
organic compounds, essential fatty acids, minerals,
and chelating agents which may either precipitate or
prevent cancer development. The relationship
between dietary consumption and cancer development
is not clear and further investigation continues.
Noteworthy is the report on the presence of high
levels of cesium [Cs] and rubidium [Rb] in food
along with availability of various supportive
compounds as vitamins A and C, along with zinc and
selenium in diet of populations residing in areas
with low incidence of cancer e.g., the Hopi Indian
territory in Arizona, the Hunza area in North
Pakistan, and the volcanic regions of Brazil.
The diet of these populations is similar to the
nutritive requirements for the high Ph cancer
therapy developed by Brewer's subsequent series of
physical experiments with cancer cells. In
these tests the presence of Cs+ or Rb+ in the
adjacent fluids of the tumor cell is believed to
raise the Ph of the cancer cell where mitosis will
cease resulting in reduction of life span of the
cancer cell. The introduction of such alkaline
pH by these alkali salts may also neutralize the
acidic and toxic material within the cancer cell.
This report combines the use of CsCl with various
supportive agents. which have been hypothesized both
to enhance the entry of Cs+ into the cancer cell and
to stimulate the immune response, in the treatment
of various cancers.
Treatment was performed on 50 patients during the
last three years at Life Sciences Universal
Medical Clinics in Rockville MD and in Washington
D.C. All patients were terminal subjects with
generalized metastatic disease. Forty-seven of
the 50 patients studies had received maximal
modalities of treatment, i.e., surgery, radiation,
and various chemotherapy, before metabolic
Cs-treatment was initiated. Three patients
were comatose and 14 of the patients were considered
terminal due to previous treatments outcome and
The Cs-treatment was given in conjunction of other
supportive compounds under diet control in addition
to the utilization of specific compounds to produce
adequate circulation and oxygenation.
According to individual cases CsCl was given at
daily dosages of 6 to 9 grams in 3 equally divided
doses, with vitamin A-emulsion (100,000 to 300,000
U), vitamin C (4 to 30 grams), zinc (80 to 100 mg)
selenium (600 to 1,200 mcg) and amygdalin (1,500 mg)
in addition to other supplementations according to
the specific needs of the patient. The diet
consisted mainly of whole grains, vegetables,
linolenic acid rich oils (linseed, walnut, soy,
wheat germ) and other supplemental food. To
increase efficiency of the treatment and improve the
circulation and oxygenation, the patients received
the chelating agent EDTA, dimethylsulfoxide (DMSO)
and also a combination of vitamins, K and Mg salts.
1 summarizes the results of the Cs-treatment of 50
cancer patients studied over 3 years. One of
the most striking effects of the treatment was the
disappearance of pain in all patients within 1
to 3 days after initiation of the Cs-therapy.
Twenty-eight patients were initially treated with
CsCl between April, 1981 to October, 1982.
They were subjected to various cancer therapies,
e.g., surgery, radiation, and chemotherapy, and were
considered terminal cases with metastatic disease
except for 3 patients who were not previously
treated. Three patients were comatose at the
time of the Cs treatment. Thirteen patients
died within less than 2 weeks of treatment.
Each patient showed a reduction in tumor mass by the
Cs-treatment. Of the breast cancer patients,
the most impressive effect was seen in a female
patient who was comatose at the beginning of the
Cs-treatment and was considered a terminal case.
The Cs-therapy, with other ingredients used, was
immediately instituted by nasogastric route because
there was no cooperation from the patient.
The daily CsCl dose given amounted to 30 grams, 10
grams given 3 times daily. The patient was
able to leave after 5 days of treatment.
The next most frequent cancer treated was of unknown
primary. Treatment of 8 cases showed a death
rate of 2 within 14 days of treatment and an
additional 2 deaths within 12 months while 4 of the
patients are still living. In one case, an
autopsy was made in a patient after one week of
Cs-treatment and showed a complete disappearance of
the cancer. There were 7 cases of colon cancer
patients who were treated with CsCl. Two of
these patients died within 14 days, one of the
patients had previous massive chemotherapy, and
little time was available to restore her metabolic
condition. The previous existing infiltration
of the abdominal wall disappeared. However, no
consent was given for an autopsy.
In one lymphoma case the patient displayed an
unusually large abdomen which was hard and he
weighed approximately 250 pounds. The
massively enlarged abdomen began to decline in
volume, i.e., a loss of approximately 120 pounds of
body weight was noted after 3 months of the Cs-
therapy. The spleen which was originally
maximally enlarged and reaching into the pelvis was
reduced to almost normal size. The liver
position was down to about the level of the
umbilicus and was also reduced to normal size in 3
months. The patient is still living after 3
years after his discharge. Unfortunately,
there is no follow-p on this patient and he is being
maintained on chemotherapy.
The High Oxygen Environment
Nobel Laureate Otto Warburg demonstrated
that normal cells would become irreversibly
cancerous if the environment they rested in had
their oxygen levels lowered by 35% for 48 hours.
Cancer Cells CANNOT Live in a High Oxygen
The High Enzyme Environment
Cancer cells develop a protein coating 13 times
thicker than normal cells. This makes it
difficult for the immune system to attack them.
By ingesting high doses of pancreatin, you can
actually dissolve cancer cells inside the body.